Inventory, Net in USD of Axsome Therapeutics, Inc. from Q2 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Axsome Therapeutics, Inc. quarterly Inventory, Net history and growth rate from Q2 2022 to Q3 2025.
  • Axsome Therapeutics, Inc. Inventory, Net for the quarter ending September 30, 2025 was $23.8M, a 66.7% increase year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Growth (%)

Axsome Therapeutics, Inc. Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $23.8M +$9.51M +66.7% Sep 30, 2025 10-Q 2025-11-03
Q2 2025 $18.4M +$3.22M +21.2% Jun 30, 2025 10-Q 2025-08-04
Q1 2025 $16.3M +$736K +4.72% Mar 31, 2025 10-Q 2025-05-05
Q4 2024 $15.7M +$597K +3.94% Dec 31, 2024 10-Q 2025-11-03
Q3 2024 $14.3M +$4.28M +42.9% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $15.2M +$5.97M +64.5% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $15.6M +$7.64M +96.3% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $15.1M +$10.8M +250% Dec 31, 2023 10-K 2025-02-18
Q3 2023 $9.99M +$7.88M +375% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $9.25M -$1.07M -10.4% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $7.94M Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $4.32M Dec 31, 2022 10-K 2024-02-23
Q3 2022 $2.1M Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $10.3M Jun 30, 2022 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.